A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
This study is currently recruiting participants.
Verified April 2013 by Taiwan Liposome Company
Sponsor:
Taiwan Liposome Company
Information provided by (Responsible Party):
Taiwan Liposome Company
ClinicalTrials.gov Identifier:
NCT01425996
First received: August 15, 2011
Last updated: April 16, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2015 |
| Estimated Primary Completion Date: | April 2015 (Final data collection date for primary outcome measure) |